$LYCA 4 SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Touami Sofia, Chief Business Officer Granted 68,755 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Staben Steven, Chief Scientific Officer Granted 110,896 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Bachrodt Amy, Chief Financial Officer Granted 399,746 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Lee Chin Hyok, Chief Medical Officer Granted 73,191 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Trombley Aetna Wun, Director Granted 443,586 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Henderson Jane, Director Granted 57,666 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Fischer Laurent, Director Granted 13,307 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)
26 Oct 2026	Form 4: Rieflin William Jl, Director Granted 24,840 Stock Option (Right to Buy) · Granted 20,000 Stock Option (Right to Buy)

Comments